NCT03355976 2025-10-09BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell CarcinomasBrown UniversityPhase 2 Active not recruiting46 enrolled
NCT01582204 2025-08-05Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell CarcinomaMemorial Sloan Kettering Cancer CenterPhase NA Active not recruiting17 enrolled